Eczema Trial, Recruiting NCT06362629 Sponsor: West China Hospital Condition: Eczema
Back to Eczema

Eczema Trial, Recruiting

NCT06362629
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Atopic Dermatitis (a type of skin condition involving dryness and itching), aged between 1 and 75 years old
  • People who are able to communicate in Chinese and have basic reading and writing skills
  • People (or their guardian, for younger participants) who own a smartphone or tablet and are comfortable using it

Who may not be able to join:

  • People who have a mental illness or personality disorder
  • People who have difficulty with language, hearing, or communication
  • People who have serious existing health conditions, such as heart or lung problems, liver problems, kidney problems, blood disorders, cancer, or other serious illnesses
  • People who, for any other reason, the trial site considers unsuitable for taking part in a clinical trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jingyi Li, M.D., West China Hospital

Phone: +8618980605704

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
West China Hospital
Registry
ClinicalTrials.gov
Start date
1 September 2024
Est. completion
31 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The overall efficiency rate of treating objectives including PP-NRS, EASI, SCORAD, POEM, and DLQI at 12 weeks after treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov